Blackstone Group LP Has Trimmed Stake in Targa Res (TRGP) as Shares Declined; Pacira Pharmaceuticals (PCRX) Shares Rose While Consonance Capital Management LP Has Increased Stake by $32.01 Million

Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) Logo

Mitchell Blutt increased its stake in Pacira Pharmaceuticals Inc (PCRX) by 64.44% based on its latest 2018Q1 regulatory filing with the SEC. Consonance Capital Management Lp bought 1.03M shares as the company’s stock rose 11.79% while stock markets declined. The hedge fund run by Mitchell Blutt held 2.63 million shares of the health care company at the end of 2018Q1, valued at $82.08 million, up from 1.60M at the end of the previous reported quarter. Consonance Capital Management Lp who had been investing in Pacira Pharmaceuticals Inc for a number of months, seems to be bullish on the $1.27B market cap company. The stock increased 1.64% or $0.5 during the last trading session, reaching $31.05. About 579,048 shares traded. Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) has declined 23.22% since June 29, 2017 and is downtrending. It has underperformed by 35.79% the S&P500. Some Historical PCRX News: 06/04/2018 – Pacira: Approval for Indication Was Based on Positive Data From Phase 3 Study in Brachial Plexus Block for Shoulder Surgerie; 22/04/2018 – DJ Pacira Pharmaceuticals Inc, Inst Holders, 1Q 2018 (PCRX); 03/05/2018 – PACIRA 1Q REV. $74.6M, EST. $74.0M; 15/05/2018 – Nexthera Capital Buys New 1.2% Position in Pacira; 03/05/2018 – PACIRA PHARMACEUTICALS INC – REITERATED ITS FULL YEAR 2018 FINANCIAL GUIDANCE; 06/04/2018 – $PCRX approved. Narrow label for brachial plexus block; 06/04/2018 – $PCRX Here is the full Pacira Pharma Exparel label; 03/05/2018 – Pacira Pharmaceuticals 1Q Rev $74.6M; 01/05/2018 – Pacira Presenting at Bank of America Conference May 15; 06/04/2018 – Pacira Announces FDA Approval of Supplemental New Drug Application for EXPAREL® as a Nerve Block to Produce Regional Analgesia

Blackstone Group Lp decreased its stake in Targa Res Corp (TRGP) by 96.05% based on its latest 2018Q1 regulatory filing with the SEC. Blackstone Group Lp sold 6.28M shares as the company’s stock declined 0.85% with the market. The institutional investor held 258,302 shares of the public utilities company at the end of 2018Q1, valued at $11.37 million, down from 6.54M at the end of the previous reported quarter. Blackstone Group Lp who had been investing in Targa Res Corp for a number of months, seems to be less bullish one the $11.02 billion market cap company. The stock increased 2.03% or $1 during the last trading session, reaching $50.21. About 1.84 million shares traded. Targa Resources Corp. (NYSE:TRGP) has declined 3.47% since June 29, 2017 and is downtrending. It has underperformed by 16.04% the S&P500. Some Historical TRGP News: 27/03/2018 – Targa Resources Closes Below 200-Day Moving Average: Technicals; 18/04/2018 – Targa Resources Corp. Announces Quarterly Dividends; 09/03/2018 TARGA RESOURCES CORP TRGP.N : UBS RAISES TARGET PRICE TO $59 FROM $58; 05/04/2018 – TARGA RESOURCES PARTNERS- AMOUNT OF OFFERING WAS INCREASED FROM PREVIOUSLY ANNOUNCED OFFERING SIZE OF $750.0 MLN; 15/05/2018 – Scopia Capital Management LP Exits Position in Targa Re; 27/03/2018 – Targa Resources Announces Additional Delaware Basin Processing Expansions, an Extension of its Grand Prix NGL Pipeline into Oklahoma and Potential Asset Sales; Also Posts Updated Investor Presentation; 27/03/2018 – TARGA RESOURCES CORP TRGP.N – TARGA’S TOTAL GROWTH CAPITAL SPENDING ON GRAND PRIX IN 2018 IS NOW ESTIMATED TO BE APPROXIMATELY $1.65 BLN; 03/05/2018 – Kirby Corp Agrees to Purchase Pressure Barges From Targa Resources Corp; 08/05/2018 – Targa Resources at Deutsche Bank MLP & Pipeline Day Tomorrow; 17/05/2018 – Targa Resources 10.3% Owned by Hedge Funds

More notable recent Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) news were published by: Nasdaq.com which released: “Aetna DocFind Directory Now Highlights Providers Offering Opioid Alternatives, Including EXPAREL®” on June 15, 2018, also Benzinga.com with their article: “56 Biggest Movers From Yesterday” published on June 22, 2018, Nasdaq.com published: “Consolidated Research: 2018 Summary Expectations for Microchip Technology, New Jersey Resources, Brown …” on June 18, 2018. More interesting news about Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) were released by: Marketwatch.com and their article: “Heron Therapeutics stock rockets 30% on high hopes for post-surgery pain treatment” published on June 21, 2018 as well as Streetinsider.com‘s news article titled: “Pacira Pharma (PCRX) Reports Licensing Agreement with Nuance Biotech for EXPAREL in China” with publication date: June 19, 2018.

Investors sentiment decreased to 0.93 in Q1 2018. Its down 0.47, from 1.4 in 2017Q4. It is negative, as 32 investors sold PCRX shares while 51 reduced holdings. 28 funds opened positions while 49 raised stakes. 41.78 million shares or 4.29% more from 40.06 million shares in 2017Q4 were reported. Stephens Invest Management Grp Ltd Llc holds 1.05M shares or 0.71% of its portfolio. Alliancebernstein Lp, a New York-based fund reported 58,648 shares. Point72 Asset Mngmt Limited Partnership has 11,700 shares. Benjamin F Edwards & holds 0.02% of its portfolio in Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) for 6,308 shares. Pnc Finance Svcs Grp reported 5,443 shares or 0% of all its holdings. Alps Advisors reported 54,413 shares. State Street holds 0% or 1.16M shares in its portfolio. Goldman Sachs Inc, a New York-based fund reported 241,261 shares. Td Asset Inc holds 29,100 shares or 0% of its portfolio. Pub Employees Retirement Systems Of Ohio invested 0.01% in Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX). 461,102 were reported by Balyasny Asset Mngmt Ltd. Voya Investment Management Lc has invested 0% of its portfolio in Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX). Nelson Van Denburg & Campbell Wealth Mgmt Grp Incorporated Ltd reported 2,365 shares. Metropolitan Life Ins New York holds 12,972 shares or 0% of its portfolio. Ameritas Investment Prns holds 0.01% or 3,449 shares in its portfolio.

Consonance Capital Management Lp, which manages about $513.80M and $1.09B US Long portfolio, decreased its stake in Corcept Therapeutics Inc (NASDAQ:CORT) by 591,089 shares to 5.19 million shares, valued at $85.35 million in 2018Q1, according to the filing. It also reduced its holding in Corindus Vascular Robotics I by 1.41 million shares in the quarter, leaving it with 4.57M shares, and cut its stake in Gw Pharmaceuticals Plc (NASDAQ:GWPH).

Since January 10, 2018, it had 0 insider buys, and 9 sales for $2.87 million activity. The insider STACK DAVID M sold $667,764. $45,138 worth of Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) was sold by Scranton Richard. Williams Kristen Marie had sold 2,040 shares worth $67,361. Another trade for 771 shares valued at $26,137 was made by HASTINGS PAUL J on Monday, June 4. Shares for $26,449 were sold by Riker Lauren Bullaro. 373 shares valued at $12,316 were sold by Weiland Robert J. on Monday, June 4.

Among 22 analysts covering Pacira Pharmaceuticals (NASDAQ:PCRX), 10 have Buy rating, 1 Sell and 11 Hold. Therefore 45% are positive. Pacira Pharmaceuticals had 110 analyst reports since July 28, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Friday, September 29 by Canaccord Genuity. The firm has “Neutral” rating by Janney Capital given on Friday, December 30. H.C. Wainwright initiated Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) on Tuesday, January 3 with “Buy” rating. H.C. Wainwright reinitiated it with “Buy” rating and $52 target in Thursday, November 9 report. The firm earned “Hold” rating on Wednesday, November 8 by BMO Capital Markets. Wedbush maintained Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) on Wednesday, March 7 with “Buy” rating. The firm has “Buy” rating given on Monday, April 9 by Piper Jaffray. As per Wednesday, October 11, the company rating was maintained by RBC Capital Markets. BMO Capital Markets initiated the shares of PCRX in report on Wednesday, June 29 with “Underperform” rating. As per Wednesday, August 2, the company rating was maintained by Mizuho.

Among 19 analysts covering Targa Resources (NYSE:TRGP), 11 have Buy rating, 0 Sell and 8 Hold. Therefore 58% are positive. Targa Resources had 92 analyst reports since August 5, 2015 according to SRatingsIntel. The rating was initiated by Macquarie Research with “Outperform” on Friday, April 21. The stock of Targa Resources Corp. (NYSE:TRGP) has “Buy” rating given on Friday, May 4 by Stifel Nicolaus. RBC Capital Markets maintained it with “Buy” rating and $60.0 target in Monday, September 25 report. Barclays Capital downgraded Targa Resources Corp. (NYSE:TRGP) on Tuesday, July 18 to “Equal-Weight” rating. The firm earned “Mkt Perform” rating on Monday, January 4 by Raymond James. The stock of Targa Resources Corp. (NYSE:TRGP) earned “Hold” rating by Jefferies on Wednesday, April 5. The stock has “Hold” rating by BMO Capital Markets on Tuesday, August 15. Stifel Nicolaus maintained Targa Resources Corp. (NYSE:TRGP) rating on Monday, July 17. Stifel Nicolaus has “Buy” rating and $5400 target. The firm earned “Equal Weight” rating on Monday, May 2 by Barclays Capital. Stifel Nicolaus upgraded it to “Buy” rating and $50 target in Thursday, November 3 report.

Blackstone Group Lp, which manages about $19.89B US Long portfolio, upped its stake in Spdr S&P 500 Etf Tr (Put) (SPY) by 159,895 shares to 160,000 shares, valued at $42.10 million in 2018Q1, according to the filing.

Investors sentiment increased to 1.33 in 2018 Q1. Its up 0.28, from 1.05 in 2017Q4. It increased, as 31 investors sold TRGP shares while 105 reduced holdings. 56 funds opened positions while 125 raised stakes. 202.60 million shares or 4.63% more from 193.64 million shares in 2017Q4 were reported. Fdx Inc, a California-based fund reported 4,863 shares. Shanda Asset reported 72,900 shares. Zimmer Ptnrs Limited Partnership accumulated 4.53 million shares. Moreover, Mai Management has 0.26% invested in Targa Resources Corp. (NYSE:TRGP). Mariner Limited Liability owns 23,156 shares. Apg Asset Nv has 265,024 shares. Cubist Systematic Strategies Ltd Liability Corp has invested 0.05% in Targa Resources Corp. (NYSE:TRGP). North Star Investment Mgmt has invested 0.01% of its portfolio in Targa Resources Corp. (NYSE:TRGP). 920 were accumulated by American Research & Management. Highlander Cap Mgmt Limited Liability Com has invested 0.02% in Targa Resources Corp. (NYSE:TRGP). Amp Capital Invsts Limited holds 97,466 shares or 0.02% of its portfolio. Brookfield Asset invested 1.89% in Targa Resources Corp. (NYSE:TRGP). Paloma Prns Company reported 25,548 shares. Avalon Advsr Ltd invested in 7,072 shares. 16,206 were reported by Strs Ohio.

More notable recent Targa Resources Corp. (NYSE:TRGP) news were published by: Globenewswire.com which released: “Targa NGL Pipeline Company Launches Open Season” on June 15, 2018, also Fool.com with their article: “This Little-Known High-Yield Stock Just Became a Whole Lot More Attractive” published on June 20, 2018, Globenewswire.com published: “Targa Resources Partners LP Announces Monthly Distribution on Preferred Units” on June 15, 2018. More interesting news about Targa Resources Corp. (NYSE:TRGP) were released by: Benzinga.com and their article: “Barclays Downgrades Targa, DCP Midstream On Decelerating Permian Volumes; Enable Midstream Upgraded” published on June 12, 2018 as well as Bizjournals.com‘s news article titled: “Here’s how much Houston public companies spent on litigation in 2017” with publication date: June 20, 2018.

Analysts await Targa Resources Corp. (NYSE:TRGP) to report earnings on August, 2. They expect $-0.08 earnings per share, down 157.14% or $0.22 from last year’s $0.14 per share. After $-0.03 actual earnings per share reported by Targa Resources Corp. for the previous quarter, Wall Street now forecasts 166.67% negative EPS growth.

Targa Resources Corp. (NYSE:TRGP) Institutional Positions Chart